拉丁美洲国家大多被排除在更便宜的 HIV 药物 lenacapavir 交易之外。 Latin American countries mostly excluded from cheaper HIV drug lenacapavir deal.

拉丁美洲的大多数国家将无法获得低成本的 HIV 药物 lenacapavir，这限制了该地区许多人的治疗选择。 Most countries in Latin America will not have access to a lower-cost version of the HIV drug lenacapavir, limiting treatment options for many in the region. 更便宜的定价协议将很大一部分拉丁美洲国家排除在外，这影响了他们提供负担得起的医疗保健解决方案的能力。 The agreement for cheaper pricing excludes a significant portion of Latin American nations, impacting their ability to provide affordable healthcare solutions.